What’s Arcadia Biosciences, Inc. (RKDA) Downside After Forming Double Bottom?

February 15, 2018 - By Michael Collier

The chart of Arcadia Biosciences, Inc. (RKDA) shows a double bottom with $4.65 target or 7.00 % below today’s $5.00 share price. The 7 months chart pattern indicates high risk for the $10.67 million company. It was reported on Feb, 15 by Finviz.com. If the $4.65 price target is reached, the company will be worth $746,970 less. Double bottoms are rare but powerful chart patterns.

The stock decreased 1.57% or $0.08 during the last trading session, reaching $5. About 6,360 shares traded. Arcadia Biosciences, Inc. (NASDAQ:RKDA) has declined 43.32% since February 15, 2017 and is downtrending. It has underperformed by 60.02% the S&P500.

Analysts await Arcadia Biosciences, Inc. (NASDAQ:RKDA) to report earnings on March, 14. They expect $-0.10 earnings per share, up 23.08 % or $0.03 from last year’s $-0.13 per share. After $-0.11 actual earnings per share reported by Arcadia Biosciences, Inc. for the previous quarter, Wall Street now forecasts -9.09 % EPS growth.

Arcadia Biosciences, Inc. (NASDAQ:RKDA) Ratings Coverage

Among 2 analysts covering Arcadia Biosciences (NASDAQ:RKDA), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Arcadia Biosciences had 2 analyst reports since May 12, 2017 according to SRatingsIntel. The stock of Arcadia Biosciences, Inc. (NASDAQ:RKDA) has “Neutral” rating given on Friday, May 12 by PiperJaffray. The company was maintained on Friday, July 21 by Piper Jaffray.

More notable recent Arcadia Biosciences, Inc. (NASDAQ:RKDA) news were published by: Quotes.Wsj.com which released: “Arcadia Biosciences Inc. RKDA (US: Nasdaq)” on May 08, 2015, also Bizjournals.com with their article: “Arcadia Biosciences $65.6M IPO starts trading with revised price” published on May 15, 2015, Prnewswire.com published: “Morning Technical Insight on These Agricultural Chemicals Stocks — Arcadia …” on January 24, 2018. More interesting news about Arcadia Biosciences, Inc. (NASDAQ:RKDA) were released by: Businesswire.com and their article: “Arcadia Biosciences To Accelerate Agricultural Trait Development with CRISPR-Cas9” published on September 11, 2017 as well as Businesswire.com‘s news article titled: “Arcadia Biosciences Announces Passing of Board Chairman George Gosbee” with publication date: November 13, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.